1,5-anhydroglucitol (1,5-AG)

1,5-anhydroglucitol (1,5-AG) (CAS No.: 154-58-5) is a naturally occurring monosaccharide derivative and metabolically inert analog of glucose that is widely distributed in dietary sources such as grains, vegetables, and fish, and is classified as a polyol involved in carbohydrate metabolism research. It serves as a clinically relevant biomarker for short-term glycemic control, with circulating levels inversely correlated with recent hyperglycemic excursions due to competitive inhibition of its renal tubular reabsorption by glucose, leading to increased urinary loss and reduced serum concentrations. This mechanism underlies its utility as a complementary indicator to glycated hemoglobin for monitoring glucose variability over a period of approximately one to two weeks in diabetes and metabolic disorder studies. Although it does not directly engage classical enzymatic or receptor-mediated signaling pathways, its physiological behavior reflects renal glucose transport dynamics and systemic glucose homeostasis. In vitro and in vivo studies primarily utilize 1,5-AG as a functional readout rather than a pharmacologically active agent, and thus specific potency metrics such as IC50 or EC50 are not typically applicable; instead, it is measured quantitatively in biological samples to assess metabolic status. In research settings, it is commonly employed in cell-based assays, animal models, and clinical investigations to evaluate short-term glycemic fluctuations, therapeutic responses, and renal glucose handling, with experimental concentrations or dosing strategies tailored to study design and analytical methodology.